Companion Diagnostics: From Biomarker Identification to Market Entry 2014

Topics

• Promoting Personalized Medicine through Policy Strategies
• Towards Biomarker—based Personalized Healthcare: Current Status and Future Trends
• Integrating Companion Diagnostics in the Healthcare
• Regulatory Strategies to Safely Accelerate the Implementation of Companion Diagnostics
• The Impact of Genetics and Genomics in Personalized Medicine Development and Innovation
• The Future of Academic Research towards Translation for Personalized Medicine
• The Gut Microbiome: Insights for Personalized Medicine
• The Functional Status of Signal Transduction Pathways to Inform Companion Diagnostics and Personalized Cancer Drug Development
• Stratified Medicine in Autoimmune Diseases: Rheumatoid Arthritis Examples
• Biomarkers for Precision Medicine in Airway Diseases
• The Genetics of Multiple Sclerosis
• Cardiovascular Disease
• The Impact of Epigenetics on the Future of Personalized Medicine
• Therapeutic Target Areas beyond Cancer
• Ways to Making Personalized Medicine more Affordable
• Approaches to Companion Diagnostics Development

Who should Attend

• Healthcare policy makers
• International scientists and clinicians from academia, industry, and government
• Insurance sector representatives
• Regulatory experts